Literature DB >> 33590405

Development of a Large Colonoscopy-Based Longitudinal Cohort for Integrated Research of Colorectal Cancer: Partners Colonoscopy Cohort.

Mathew Vithayathil1, Scott Smith1, Sergey Goryachev2, Jennifer Nayor3, Mingyang Song4,5,6.   

Abstract

BACKGROUND AND AIMS: Conventional adenomas (CAs) and serrated polyps (SPs) are precursors to colorectal cancer (CRC). Understanding metachronous cancer risk is poor due to lack of accurate large-volume datasets. We outline the use of natural language processing (NLP) in forming the Partners Colonoscopy Cohort, an integrated longitudinal cohort of patients undergoing colonoscopies.
METHODS: We identified endoscopy quality data from endoscopy reports for colonoscopies performed from 2007 to 2018 in a large integrated healthcare system, Mass General Brigham). Through modification of an established NLP pipeline, we extracted histopathological data (polyp location, histology and dysplasia) from corresponding pathology reports. Pathology and endoscopy data were merged by polyp location using a four-stage algorithm. NLP and merging procedures were validated by manual review of 500 pathology reports.
RESULTS: 305,656 colonoscopies in 213,924 patients were identified. After merging, 76,137 patients had matched polyp data for 334,750 polyps. CAs and SPs were present in 86,707 (28.5%) and 55,373 (18.2%) colonoscopies. Among patients with polyps at index screening colonoscopy, 14,931 (33.4%) had follow-up colonoscopy (median 46.4, interquartile range 33.8-62.4 months); 91 (0.2%) and 1127 (2.5%) patients developed metachronous CRC and high-risk polyps (polyps ≥ 10 mm or CAs having high-grade dysplasia/villous/tublovillous histology or SPs with dysplasia). Genetic data were available for 23,787 (31.7%) patients with polyps from the Partners Biobank. The validation study showed a positive predictive value of 100% for polyp histology and locations.
CONCLUSION: We created the Partners Colonoscopy Cohort providing essential infrastructure for future studies to better understand the natural history of CRC and improve screening and post-polypectomy strategies.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC part of Springer Nature.

Entities:  

Keywords:  Advanced adenoma; Molecular epidemiology; Natural language processing; Precision screening; Serrated polyp

Mesh:

Year:  2021        PMID: 33590405     DOI: 10.1007/s10620-021-06882-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  23 in total

Review 1.  Endoscopic Recognition and Management Strategies for Malignant Colorectal Polyps: Recommendations of the US Multi-Society Task Force on Colorectal Cancer.

Authors:  Aasma Shaukat; Tonya Kaltenbach; Jason A Dominitz; Douglas J Robertson; Joseph C Anderson; Michael Cruise; Carol A Burke; Samir Gupta; David Lieberman; Sapna Syngal; Douglas K Rex
Journal:  Gastroenterology       Date:  2020-11-04       Impact factor: 22.682

2.  High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy.

Authors:  Kevin J Spring; Zhen Zhen Zhao; Rozemary Karamatic; Michael D Walsh; Vicki L J Whitehall; Tanya Pike; Lisa A Simms; Joanne Young; Michael James; Grant W Montgomery; Mark Appleyard; David Hewett; Kazutomo Togashi; Jeremy R Jass; Barbara A Leggett
Journal:  Gastroenterology       Date:  2006-08-18       Impact factor: 22.682

3.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

4.  Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths.

Authors:  Ann G Zauber; Sidney J Winawer; Michael J O'Brien; Iris Lansdorp-Vogelaar; Marjolein van Ballegooijen; Benjamin F Hankey; Weiji Shi; John H Bond; Melvin Schapiro; Joel F Panish; Edward T Stewart; Jerome D Waye
Journal:  N Engl J Med       Date:  2012-02-23       Impact factor: 91.245

5.  A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.

Authors:  Paul C Schroy; John B Wong; Michael J O'Brien; Clara A Chen; John L Griffith
Journal:  Am J Gastroenterol       Date:  2015-05-26       Impact factor: 10.864

6.  APC mutations occur early during colorectal tumorigenesis.

Authors:  S M Powell; N Zilz; Y Beazer-Barclay; T M Bryan; S R Hamilton; S N Thibodeau; B Vogelstein; K W Kinzler
Journal:  Nature       Date:  1992-09-17       Impact factor: 49.962

7.  Burden of gastrointestinal disease in the United States: 2012 update.

Authors:  Anne F Peery; Evan S Dellon; Jennifer Lund; Seth D Crockett; Christopher E McGowan; William J Bulsiewicz; Lisa M Gangarosa; Michelle T Thiny; Karyn Stizenberg; Douglas R Morgan; Yehuda Ringel; Hannah P Kim; Marco Dacosta DiBonaventura; Charlotte F Carroll; Jeffery K Allen; Suzanne F Cook; Robert S Sandler; Michael D Kappelman; Nicholas J Shaheen
Journal:  Gastroenterology       Date:  2012-08-08       Impact factor: 22.682

8.  Long-term risk of colorectal cancer after excision of rectosigmoid adenomas.

Authors:  W S Atkin; B C Morson; J Cuzick
Journal:  N Engl J Med       Date:  1992-03-05       Impact factor: 91.245

9.  Aldehyde dehydrogenase activity plays a Key role in the aggressive phenotype of neuroblastoma.

Authors:  Marjorie Flahaut; Nicolas Jauquier; Nadja Chevalier; Katya Nardou; Katia Balmas Bourloud; Jean-Marc Joseph; David Barras; Christian Widmann; Nicole Gross; Raffaele Renella; Annick Mühlethaler-Mottet
Journal:  BMC Cancer       Date:  2016-10-10       Impact factor: 4.430

10.  Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial.

Authors:  Henrik Munch Roager; Josef K Vogt; Mette Kristensen; Lea Benedicte S Hansen; Sabine Ibrügger; Rasmus B Mærkedahl; Martin Iain Bahl; Mads Vendelbo Lind; Rikke L Nielsen; Hanne Frøkiær; Rikke Juul Gøbel; Rikard Landberg; Alastair B Ross; Susanne Brix; Jesper Holck; Anne S Meyer; Morten H Sparholt; Anders F Christensen; Vera Carvalho; Bolette Hartmann; Jens Juul Holst; Jüri Johannes Rumessen; Allan Linneberg; Thomas Sicheritz-Pontén; Marlene D Dalgaard; Andreas Blennow; Henrik Lauritz Frandsen; Silas Villas-Bôas; Karsten Kristiansen; Henrik Vestergaard; Torben Hansen; Claus T Ekstrøm; Christian Ritz; Henrik Bjørn Nielsen; Oluf Borbye Pedersen; Ramneek Gupta; Lotte Lauritzen; Tine Rask Licht
Journal:  Gut       Date:  2017-11-01       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.